高通量免疫组库测序技术在血液系统肿瘤中的应用进展(5)
[30] Campana D. Minimal residual disease in acute lymphoblastic leukemia [J]. Semin Hematol，2009，46(1)：100-106.
[31] van der Velden VH，Cazzaniga G，Schrauder A，et al. Analysis of minimal residual disease by Ig/TCR gene rearrangements：guidelines for interpretation of real-time quantitative PCR data [J]. Leukemia，2007，21(4)：604-611.
[32] Faham M，Zheng J，Moorhead M，et al. Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia [J]. Blood，2012，120(26)：5173-5180.
[33] Wu D，Sherwood A，Fromm JR，et al. High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia [J]. Sci Transl Med，2012，4(134)：134r-163r.
[34] Chapman M，Warren ER，Wu CJ. Applications of next-generation sequencing to blood and marrow transplantation [J]. Biol Blood Marrow Transplant，2012，18(1 Suppl)：S151-S160.
[35] van Heijst JW，Ceberio I，Lipuma LB，et al. Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation [J]. Nat Med，2013，19(3)：372-377.
[36] Logan AC，Gao H，Wang C，et al. High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment [J]. Proc Natl Acad Sci U S A，2011，108(52)：21194-21199.
(收稿日期：2016-12-28 本文編辑：张瑜杰), 百拇医药(沈凤娇 高清平 叶柏新)
[31] van der Velden VH，Cazzaniga G，Schrauder A，et al. Analysis of minimal residual disease by Ig/TCR gene rearrangements：guidelines for interpretation of real-time quantitative PCR data [J]. Leukemia，2007，21(4)：604-611.
[32] Faham M，Zheng J，Moorhead M，et al. Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia [J]. Blood，2012，120(26)：5173-5180.
[33] Wu D，Sherwood A，Fromm JR，et al. High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia [J]. Sci Transl Med，2012，4(134)：134r-163r.
[34] Chapman M，Warren ER，Wu CJ. Applications of next-generation sequencing to blood and marrow transplantation [J]. Biol Blood Marrow Transplant，2012，18(1 Suppl)：S151-S160.
[35] van Heijst JW，Ceberio I，Lipuma LB，et al. Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation [J]. Nat Med，2013，19(3)：372-377.
[36] Logan AC，Gao H，Wang C，et al. High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment [J]. Proc Natl Acad Sci U S A，2011，108(52)：21194-21199.
(收稿日期：2016-12-28 本文編辑：张瑜杰), 百拇医药(沈凤娇 高清平 叶柏新)